Stamford, CT -- (SBWIRE) -- 01/03/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Plug Power Inc (NASDAQ:PLUG), ERBA Diagnostics Inc (NYSEMKT:ERB), Golden Minerals Co (NYSEMKT:AUMN), Biodel Inc (NASDAQ:BIOD)
Plug Power Inc (NASDAQ:PLUG) opened the session at $2.06, trading in a range of $1.89 - $2.33. The stock showed a positive performance of +50.32% in the last trading session from its previous close of $1.55 and closed at $2.33. The stock traded on a volume of 53.53 million shares and the average volume of the stock remained 10.86 million shares. Plug Power Inc., an alternative energy technology provider, engages in the design, development, commercialization, and manufacture of fuel cell systems for the industrial off-road markets worldwide. The company develops and sells a range of fuel cell systems comprising hydrogen-fueled Proton Exchange Membrane (PEM) systems. Its product line includes PEM GenDrive products for sale on commercial terms for industrial off-road consisting of forklift or material handling applications, with a focus on multi-shift high volume manufacturing and high throughput distribution sites.
For How Long PLUG will Fight for Profitability? Read This Trend Analysis report
ERBA Diagnostics Inc (NYSEMKT:ERB) traded 1.75 million shares in the last business day while the average volume of the stock remained 177,993 shares. The stock showed a positive movement of +42.86% to end at $3.90. The 52 week range of the stock remained $0.62 - $3.90. ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures, and markets diagnostic test kits or assays, and automated systems that are used to aid in the detection of disease markers in the areas of autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. It manufactures scientific and laboratory instruments, such as Mago 4, Mago 4S, and Mago Plus systems, which perform tests in an automated mode; sells other diagnostic products in Italy; and develops, manufactures, and markets diagnostic equipment, as well as raw materials, such as antigens that are used in the production of diagnostic kits.
For How Long ERB’s Gloss will Attract Investors? Find out via this report
Golden Minerals Co (NYSEMKT:AUMN) reported 1.85 million shares were exchanged during the last trade, while the average volume is about 225,231 shares. The stock escalated +33.47% and finished the day at $0.630. The beta of the stock is recorded at 8.89. Golden Minerals Company engages in the mining, exploration, and development of mineral properties in Mexico and South America. It explores for silver and gold doré bars, precipitates, lead, zinc, and pyrite concentrates. The company holds 100% interests in the Velardeña and Chicago precious metals mining operations that cover approximately 600 hectares located in the State of Durango, Mexico; and the Zacatecas silver and base metals project that consists of 195 concessions covering approximately 8,600 hectares in Mexico.
For How Long AUMN’s Gloss will Attract Investors? Find out via this report
Biodel Inc (NASDAQ:BIOD) shares rose, +21.49 percent from its previous close of $2.28 to close at $2.77. Traded with volume of 2.98 million shares in the prior session and the average volume of the stock remained 592,214 shares. Biodel Inc., a specialty biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes in the United States. It is involved in developing proprietary insulin formulations for type 1 and type 2 diabetes patients; ultra-rapid-acting insulin analog-based formulations; glucagon formulations and presentations for use as a rescue treatment for diabetes patients experiencing severe hypoglycemia or very low concentrations of blood glucose; and other recombinant human insulin-based formulations.
Why Should Investors Buy BIOD After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)